The principal and success of our constant objective for distinction is expressed in the values of our global team. The commitment and sense of responsibility of our team members are derived from the perception that every product that we make will affect another person’s health.  Consequently, our cutting-edge manufacturing systems are continuously updated to produce a range of best-in-class healthcare and wellness pharmaceuticals.



Based on the latest guidelines, an effective pharmaceutical quality system is implemented in Dayonix Pharma to ensure compliance with cGMPs by focusing on:

  • Quality management
  • Quality assurance
  • Evaluation analysis and quality risk management tools
  • Preventive action
  • Risk management
  • Continuous improvement

We focus on the development, manufacturing and the sale of quality generic medications. Offering high-quality, lower-cost alternatives to proprietary medications, we’re striving to reduce the overall healthcare costs. Through a centralized standard operating procedure and by providing a state-of-the-art supply chain, our products are differentiated by Effectiveness, Affordability, Having a low level of side effects, Reliability, Availability, and Safety from similar products in the market.

We aim to convert scientific innovation into hope and medical solutions for patients. Our deep customer relationships, accessible medicines and consistently delivered promise make us a trusted brand.



Pharmacovigilance involves identifying, quantifying, assessing and preventing risks associated with the use of drugs that are already on the market. The aims are:

  • Earlier detection of as-yet unknown adverse drug reactions and interactions
  • Identifying increasing frequency rates of known adverse drug reactions
  • Identifying and minimizing the risk factors of adverse reactions, and their possible underlying causes
  • Estimating the quantitative aspects of the benefit/risk balance of drugs, and diffusing – that information to improve regulation and rates of prescription

As a marketing authorization holder, Dayonix Pharma has an obligation in law for Pharmacovigilance implementation. A number of tools and processes are used to fulfill this obligation:

  • Detection, management and follow-up of reports of adverse reactions received from patients, caregivers, interested organizations and health professionals (physicians, pharmacists, etc.)
  • Electronic communication with the EMEA to report fast-acting adverse reactions
  • Creation of periodic updates and reports on safety
  • Creation of risk management plans